Erratum (DOI:10.1053/j.ajkd.2007.03.014);In the Literature: Prevalence and Conn-sequences of Primary Aldosteronism

American Journal of Kidney Diseases

Volumn 49, Issue 5, 2007, Pages 566-568

  Dluhy, Robert G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CAPTOPRIL; EPLERENONE; SPIRONOLACTONE;

DISEASE ASSOCIATION; EDITORIAL; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PREVALENCE; PRIMARY HYPERALDOSTERONISM; SCREENING TEST; SODIUM INTAKE; SURVIVAL;

EID: 34247512551     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.11.007     Document Type: Erratum

References (10)

1. Mulatero P., Stowasser M., Loh K.C., et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89 (2004) 1045-1050
2. Pitt B., Zannad F., Remme W., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
3. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
4. Rossi G.P., Bernini G., Caliumi C., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Cardiol 48 (2006) 2293-2300
5. Olivieri O., Ciacciarelli A., Signorelli D., et al. Aldosterone to renin ratio in a primary care setting: The Bussolengo study. J Clin Endocrinol Metab 89 (2004) 2421-2426
6. Rossi G.P., Ross E., Pavan E., et al. Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol 49 (1999) 713-723
7. Rossi G.P., Bernini G., Caliumi C., et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48 (2006) 232-238
8. Giacchetti G., Ronconi V., Turchi F., et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25 (2007) 177-786
9. Sartori M., Calo L.A., Mascagna V., et al. Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 19 (2006) 373-379
10. Calhoun D.A. Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis 48 (2006) 387-396